Patents/Assignees

Deciphera Pharmaceuticals, LLC

51 patents in portfolio

US12616683utility2026
Combination Therapy for the Treatment of Gastrointestinal Stromal Tumors
0 cites
US12617775utility2026
Processes of Making CSF-1R Inhibitors and Methods of Use Thereof
0 cites
US12582655utility2026
Methods of Treating Disorders Using CSFIR Inhibitors
0 cites
US12577249utility2026
GCN2 and Perk Kinase Inhibitors and Methods of Use Thereof
0 cites
US12551483utility2026
Formulations of Vimseltinib
0 cites
US12528787utility2026
Solid State Forms of a Kinase Inhibitor
0 cites
US12509443utility2025
CSF-1R Inhibitors and Methods of Use Thereof
0 cites
US12509456utility2025
Solid State Forms of Ripretinib
0 cites
US12485120utility2025
Methods of Treating Disorders Using CSF1R Inhibitors
0 cites
US12479833utility2025
Heteroarylaminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
0 cites
US12447149utility2025
Formulations of Vimseltinib
0 cites
US12414955utility2025
Anti-viral Activity of VPS34 Inhibitors
0 cites
US12377097utility2025
Aminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
0 cites
US12318374utility2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
0 cites
US12318373utility2025
Methods of Treating Gastrointestinal Stromal Tumors
0 cites
US12319655utility2025
RAF Kinase Inhibitors and Methods of Use Thereof
0 cites
US12295944utility2025
Methods of Treating Gastrointestinal Stromal Tumors
0 cites
US12285430utility2025
Methods of Treating Disorders Using CSF1R Inhibitors
0 cites
US12226406utility2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
0 cites
US12213967utility2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
0 cites

Page 1 of 3Next →